BOSTON--(BUSINESS WIRE)--908 Devices, a pioneer of purpose-built analytical devices for chemical analysis, today announced it has raised additional growth equity investment for acceleration into the life sciences market, completing its Series C funding and bringing the Company’s funding total to $29 Million. Industry leaders Casdin Capital, a leading life science investor; Dr. Martin Madaus, Chairman and CEO of Ortho Clinical Diagnostics; Paul Meister, former Chairman of the Board of Thermo Fis
| < Prev | Next > |
|---|
